Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.
about
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.
@en
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.
@nl
type
label
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.
@en
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.
@nl
prefLabel
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.
@en
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.
@nl
P2093
P2860
P356
P1433
P1476
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma
@en
P2093
Azra H Ligon
Brian M Alexander
David Sandak
Giovanni Parmigiani
Keith L Ligon
Kristine Pelton
Lorenzo Trippa
Neal I Lindeman
Patrick Y Wen
Rameen Beroukhim
P2860
P304
P356
10.1093/NEUONC/NOW312
P577
2017-07-01T00:00:00Z